PMID- 24657596 OWN - NLM STAT- MEDLINE DCOM- 20140625 LR - 20221207 IS - 1873-5487 (Electronic) IS - 0188-4409 (Linking) VI - 45 IP - 3 DP - 2014 Apr TI - HLA-DR polymorphism and primary biliary cirrhosis: evidence from a meta-analysis. PG - 270-9 LID - S0188-4409(14)00040-X [pii] LID - 10.1016/j.arcmed.2014.03.002 [doi] AB - BACKGROUND AND AIMS: We undertook this study to review and quantitatively analyze the association between human leukocyte antigen (HLA) DR polymorphisms and susceptibility of primary biliary cirrhosis (PBC). METHODS: All relevant publications on the association between HLA-DR polymorphisms and PBC were searched through June 2013. Odds ratios (OR) and confidence intervals (CI) for the comparisons between case and control group were calculated. Statistical analysis was performed using Stata 11.0 software. RESULTS: Nineteen articles (or 20 studies including the substudies) were identified. For DR*7 allele, the ORs (95% CIs) were 1.530 (1.310, 1.788), 1.757 (1.285, 2.403) and 1.495 (1.211, 1.845) in overall, Asian and European populations, respectively. For DR*8 alleles, the ORs (95% CIs) were 3.158 (1.822, 5.475), 2.803 (2.420, 3.247) and 3.056 (2.573, 3.629) in Asian, American and European subgroups, respectively. The subgroup analysis for DR*11 and DR*13 showed a significant association in Asian and European population. For DR*12 and *15 alleles, the overall ORs (95% CIs) were 0.551 (0.404, 0.753) and 0.721 (0.607, 0.857). However, in subgroup analysis for DR*12 allele, the association was only found in Asian population. In addition, statistical significance exists in American and European populations in the subgroup analysis for DR*15 allele. CONCLUSION: Our meta-analysis suggested that HLA-DR *7 and *8 allele polymorphisms contributed to the susceptibility of PBC, whereas DR*11, *12, *13 and *15 allele polymorphisms are protective factors in certain population. CI - Copyright (c) 2014 IMSS. Published by Elsevier Inc. All rights reserved. FAU - Li, Man AU - Li M AD - Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University, Shijiazhuang, China. FAU - Zheng, Hao AU - Zheng H AD - Department of Ultrasonography, Hebei Chest Hospital, Shijiazhuang, China. FAU - Tian, Qing-bao AU - Tian QB AD - Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University, Shijiazhuang, China. FAU - Rui, Mei-na AU - Rui MN AD - Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University, Shijiazhuang, China. FAU - Liu, Dian-wu AU - Liu DW AD - Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University, Shijiazhuang, China. Electronic address: dwliu1956@hotmail.com. LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't DEP - 20140321 PL - United States TA - Arch Med Res JT - Archives of medical research JID - 9312706 RN - 0 (HLA-DR Antigens) SB - IM MH - Alleles MH - Asian People MH - Genetic Predisposition to Disease MH - HLA-DR Antigens/*genetics/immunology MH - Humans MH - Liver Cirrhosis, Biliary/ethnology/*genetics/immunology MH - Polymorphism, Genetic MH - White People OTO - NOTNLM OT - HLA OT - Meta-analysis OT - Polymorphism OT - Primary biliary cirrhosis EDAT- 2014/03/25 06:00 MHDA- 2014/06/26 06:00 CRDT- 2014/03/25 06:00 PHST- 2013/09/22 00:00 [received] PHST- 2014/02/26 00:00 [accepted] PHST- 2014/03/25 06:00 [entrez] PHST- 2014/03/25 06:00 [pubmed] PHST- 2014/06/26 06:00 [medline] AID - S0188-4409(14)00040-X [pii] AID - 10.1016/j.arcmed.2014.03.002 [doi] PST - ppublish SO - Arch Med Res. 2014 Apr;45(3):270-9. doi: 10.1016/j.arcmed.2014.03.002. Epub 2014 Mar 21.